MACURE PHARMA ApS: Financial statements 2018
CVR: 35234748
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
MACURE PHARMA ApS (CVR 35234748) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 10,257,349 and a net result of DKK 5,335,423 compared with DKK 8,913,444 the year before. That is a decrease of 28.7% compared with the year before. Equity in the 2018 report amounted to DKK 10,506,680. The solvency ratio was 31%. The company had 5 employees in the financial year.
- Gross Profit
- DKK 10,257,349
- Profit/Loss
- DKK 5,335,423
- Equity
- DKK 10,506,680
- Total Assets
- DKK 33,942,095
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 10.3 mio. | 5.3 mio. | 10.5 mio. | 5 |
| 2017 | - | 14.4 mio. | 8.9 mio. | 12 mio. | 4 |
| 2016 | - | 13.3 mio. | 9.1 mio. | 5.5 mio. | - |
| 2015 | - | 680 t. | 407 t. | 823 t. | - |
| 2014 | - | 214 t. | 66 t. | 417 t. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
MACURE PHARMA ApS has published its annual report for 2017. Gross profit came to DKK 14,376,903, and the net result was DKK 8,913,444.
As of March 1, 2018, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of MACURE PHARMA ApS.
As of February 28, 2018, Din Revisor Frederiksberg P/S Godkendte Revisorer has stepped down as auditor of MACURE PHARMA ApS.
About MACURE PHARMA ApS
MACURE PHARMA ApS is a Danish company of the type Anpartsselskab based in København NV, founded in 2013. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Mads Renlef Henningsen and Lars Mark Poulsen. The company is owned by Nest Egg ApS. The company has 3 employees (2018). In 2025, the company reported a gross profit of DKK 47,649,382 and a net result of DKK 11,054,004 compared with DKK 8,495,013 the year before. Equity in the 2025 report amounted to DKK 18,033,649.